New research found that a single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix) may offer a similar level of protection against the serotypes of HPV types 16 and 18, which cause 70 percent of cervical cancers as the current two and three dose schedules. The findings come from a new analysis of two large phase
Cervarix
Vaccines that protect adolescent girls and women from the human papillomavirus (HPV) and from developing cervical cancer may also help prevent oropharyngeal cancers. Worldwide the incidence of oropharyngeal cancer
The Advisory Committee on Immunization Practices recommends that all boys and girls receive the HPV vaccine before they become sexually active. Currently, there are two HPV vaccines approved
Another reason to make sure to get your HPV vaccine! I mean, besides preventing many cancer, there seems to be a link between HPV and the dreaded pregnancy complication, preeclampsia.